Does CABERGOLINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with CABERGOLINE (Cabergoline). This represents 0.3% of all adverse event reports for CABERGOLINE.
6
Reports of Malignant neoplasm progression with CABERGOLINE
0.3%
of all CABERGOLINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CABERGOLINE?
Of the 6 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABERGOLINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CABERGOLINE Cause?
Drug ineffective (249)
Headache (142)
Off label use (129)
Nausea (103)
Maternal exposure during pregnancy (100)
Dizziness (94)
Cerebrospinal fluid leakage (78)
Fatigue (71)
Malaise (64)
Condition aggravated (61)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CABERGOLINE Alternatives Have Lower Malignant neoplasm progression Risk?
CABERGOLINE vs CABOTEGRAVIR
CABERGOLINE vs CABOTEGRAVIR\RILPIVIRINE
CABERGOLINE vs CABOZANTINIB
CABERGOLINE vs CABOZANTINIB S-MALATE
CABERGOLINE vs CAFFEINE